Authors: M. Lubušký 1,2; M. Procházka 1; L. Krejčová 3; M. Větr 1; J. Šantavý 2; Milan Kudela 1 Authors‘ workplace: Gynekologicko-porodnická klinika LF UP a FN, Olomouc, přednosta prof. MUDr. M. Kudela, CSc. 1; Ústav lékařské genetiky a fetální medicíny LF UP a FN, Olomouc, přednosta prof. MUDr. J. Šantavý, CSc. 2; Ministerstvo zdravotnictví ČR, oddělení péče o matku a dítě, odbor zdravotní péče a farmacie, Praha 3 Published in: Ceska Gynekol 2006; 71(3): 173-179 Category: Original Article
Objective: The objective of this review was to assess the effects of antenatal anti-D immunoglobulin on the incidence of Rhesus D alloimmunization when given to Rh-negative women without anti-D antibodies and assess the effects of giving anti-D to Rhesus negative women, with no anti-D antibodies, who had given birth to a Rhesus positive infant.
Design: A review article.
Setting: Department of Obstetrics and Gynecology, Department of Medical Genetics and Fetal Medicine, University Hospital, Olomouc, Ministry of Health, Czech Republic. Subject and Method: We searched the Cochrane Pregnancy and Childbirth Group trials register, refence lists of relevant articles and bibliographies.
Conclusion: The risk of Rhesus D alloimmunization during or immediately after a first pregnancy is about 1%. Administration of 100 μg (500 IU) anti-D to women in their first pregnancy can reduce this risk to about 0.2% without, to date, any adverse effects. Anti-D, given within 72 hours after childbirth, reduces the risk of RhD alloimmunization in Rhesus negative women who have given birth to a Rhesus positive infant. However the evidence on the optimal dose is limited.
Key words: anti-D, rhesus alloimmunization
Don‘t have an account? Create new account
Enter the email address that you registered with. We will send you instructions on how to set a new password.
